Donanemab

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Name

Type

Language

LY 3002813

Preferred Name

English

Donanemab

Official Name

English

LY-3002813

Code

English

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS APP (AMYLOID BETA A4 PRECURSOR PROTEIN) A BETA 3-PYROGLUTAMYL PEPTIDES, A.BETA. 3 (3-X)), HUMANIZED MONOCLONAL ANTIBODYGAMMA1 HEAVY CHAIN HUMANIZED (1-444) (VH (HOMO SAPIENS IGHV1-3*01 (84.7%)-(IGHD)-IGHJ4*01 (

Systematic Name

English

DONANEMAB [USAN]

Common Name

English

donanemab [INN]

Common Name

English

Donanemab [WHO-DD]

Common Name

English

Immunoglobulin G1, anti-(human pyroglutamyl A? (3-x) peptide)(human clone LY3002813 ?1-chain), disulfide with human clone LY3002813 ?-chain, dimer

Common Name

English

Code System Code Type Description

CAS

1931944-80-7

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

INN

10922

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

SMS_ID

300000005929

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

WIKIPEDIA

Donanemab

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

USAN

LM-184

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

FDA UNII

1ADB65P1KK

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

NCI_THESAURUS

C166484

Created by admin on Wed Apr 02 01:40:44 GMT 2025 , Edited by admin on Wed Apr 02 01:40:44 GMT 2025

PRIMARY

ACTIVE MOIETY


					1ADB65P1KK

Donanemab